The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.

about

The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.

Item

http://www.wikidata.org/entity/Q50061760

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The Shifting Paradigm for Brea ...... oing Neoadjuvant Chemotherapy.

@en

The Shifting Paradigm for Brea ...... oing Neoadjuvant Chemotherapy.

@nl

type

Item

label

The Shifting Paradigm for Brea ...... oing Neoadjuvant Chemotherapy.

@en

The Shifting Paradigm for Brea ...... oing Neoadjuvant Chemotherapy.

@nl

prefLabel

The Shifting Paradigm for Brea ...... oing Neoadjuvant Chemotherapy.

@en

The Shifting Paradigm for Brea ...... oing Neoadjuvant Chemotherapy.

@nl

P1476

The Shifting Paradigm for Brea ...... oing Neoadjuvant Chemotherapy.

@en

P2093

Avisek Datta

http://www.w3.org/2001/XMLSchema#string

Chi-Hsiung Wang

http://www.w3.org/2001/XMLSchema#string

Gaurav Ajmani

http://www.w3.org/2001/XMLSchema#string

Katharine Yao

http://www.w3.org/2001/XMLSchema#string

Olga Kantor

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment

Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.

Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base.

Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017.

Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer.

P2888

s10434-017-6217-4

P304

164-172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-017-6217-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092632106

http://www.w3.org/2001/XMLSchema#string

P698

29127538

http://www.w3.org/2001/XMLSchema#string